FDA warns public from buying, using Brilliant Skin Essentials products

The Food and Drug Administration (FDA) warns the public from purchasing and using the adulterated cosmetic product BRILLIANT SKIN ESSENTIALS products.

FDA said its BRILLIANT SKIN ESSENTIALS WHITENING FACIAL TONER, REJUVENATING FACIAL CREAM, and REJUVENATING FACIAL TONER tested positive for the presence of HYDROQUINONE and TRETINOIN. Such ingredients are not allowed to be part of a cosmetic product as per Annex II Part 1 of the Cosmetic Directive.

Products containing Hydroquinone and/or Tretinoin (Retinoic Acid) shall be classified as home remedy, over-the-counter, or prescription drug depending on the amount present as per Administrative Order No. 13 s. 1999.

The aforementioned adulterated product is found to be non-compliant with the existing standards, and, thus pose potential hazards to the consuming public. The use of adulterated cosmetic products may result to adverse reactions, including but not limited to, skin irritation, itchiness, anaphylactic shock and organ failure.

In light of the foregoing, the public is advised not to purchase the aforementioned adulterated product. Moreover, the public is advised to always check if a cosmetic product is notified with the FDA. The FDA website (www.fda.gov.ph.) has a Search feature which may be used by typing in the name of the product before purchasing.

Also read: FDA warns against using veterinary product for COVID-19

FDA warns public from buying, using

Also read: FDA warns against using veterinary product for COVID-19

FDA warns public from buying, using Brilliant Skin Essentials products

products

All concerned establishments are warned not to distribute adulterated cosmetic products.

All FDA Regional Field Offices and Regulatory Enforcement Units, in coordination with law enforcement agencies and Local Government Units, are requested to ensure that violative products are not sold or made available in the market or areas of jurisdiction.

Kindly contact the FDA Center for Cosmetics Regulation and Research through e-mail at ccrr@fda.gov.ph, or call (02) 8857-1900 loc. 8113 or 8107.

To report any sale or distribution of the aforementioned cosmetic product, the online reporting facility, eReport can be accessed at www.fda.gov.ph/ereport.

Dissemination of this advisory to all concerned is hereby requested.

Brilliant Skin Essentials has yet to issue a statement regarding the FDA warning.